Dr. Reddy’s Laboratories Ltd ADR annual earnings per share (EPS) for fiscal TTM was ₹39.81, a decrease of 26.4% from ₹54.11 in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | ₹39.81 | ₹54.11 | ₹67.77 | ₹66.80 | ₹54.17 | ₹28.34 | ₹0.28 | ₹23.48 | ₹22.62 | ₹11.80 | ₹14.42 | ₹23.40 | ₹25.95 | ₹25.21 | ₹19.69 | ₹16.76 | ₹12.99 | ₹1.26 | ₹-6.14 | ₹5.55 | ₹11.74 |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | ₹5.36 | ₹2.68 | ₹14.52 | ₹17.25 | ₹17.02 | ₹19.10 | ₹16.94 | ₹15.05 |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RDY metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All RDY financial statements → Interactive RDY charts →
About TickerBase · Data methodology & sources · Privacy · Terms